Trial Profile
An open-label extension study of phase 3 clinical trial of duloxetine in children and adolescents with depressive disorder
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 10 Jan 2022
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Depressive disorders
- Focus Adverse reactions
- Sponsors Shionogi
- 22 Dec 2021 Status changed from recruiting to discontinued.
- 13 Feb 2018 New trial record